test

TLDR: Nope.

These days I commonly get the question ”Does vaccination of dogs with available canine influenza vaccines protect them from H5N1 avian flu?” While we don’t have any hard data on this, we still have a pretty good idea of the answer.

One of the challenges with flu vaccination (in any species, including humans) is the lack of good cross protection between strains (e.g. H3N2 vs H1N1 vs H5N1). In general, we assume there’s little to no cross-protection, and organizations such as CDC, Public Health Agency of Canada and WHO have stated that seasonal flu vaccines don’t offer any protection to people against H5N1 flu. 

That said, theoretically there there may be a bit of protection, though it’s hard to have confidence in that based on data from older lab animal studies. One study (Rockman et al. J Virol 2013) showed that ferrets vaccinated with human seasonal flu vaccine had partial protection against challenge with H5N1 flu. They determined that this was from the H1N1 component of the vaccine, and was predominantly from the neuraminidase (N) part (H5N1 and H1N1 have the same N1). While we typically pay more attention to the H component for vaccination, the similarity in N may be useful. That means there may be some protection of people from H5N1 flu if they’re vaccinated for seasonal flu, but not a lot, and we have to be careful extrapolating too much from older studies using different types of H5N1 in lab animal models. 

Canine flu vaccines target H3N2 canine flu, plus or minus H3N8 canine flu strain. (Realistically we only care about H3N2 now, since H3N8 appears to have disappeared as of a few years ago.) Those are quite different from H5N1 avian flu in flu terms.  Since there’s no overlap in the Hs or Ns, we wouldn’t expect to even have that small theoretical cross-protection benefit. If we had an H1N1 canine flu strain, maybe there’d be some protection, but (thankfully!) we don’t.

Does canine flu vaccination help protect against flu recombination? 

Recombination (mixing) of different flu strains in the same host (human or animal) to create a new, more problematic strain is certainly a concern. We don’t want someone to be infected with seasonal flu and H5N1 flu at the same time, as that creates the potential for a new flu strain to emerge that has the hallmarks of a human flu (readily infected people, effective human-to-human transmission) but has picked up enough H5N1 bits that we don’t have protection from previous exposure or vaccination and may can cause more severe disease. So even though seasonal flu vaccines in people don’t protect against H5N1 flu, there is still benefit from reducing the human seasonal flu burden, as it in turn reduces the risk that a person will be infected with multiple flu strains at the same time, which reduces the chances of recombination.

Does the same principle apply to vaccination of dogs against canine flu? It’s a stretch. There could be some potential benefits for canine health, but probably not much benefit for public health. Canine flu is much rarer than seasonal flu is in people, so there’s less potential benefit simply because there’s less disease to prevent. There’s also less baseline protection against canine flu in dogs because it’s rare and therefore vaccination is uncommon. So from a disease transmission standpoint for dogs, a new flu strain against which they don’t have immunity isn’t that different from the current H3N2 canine flu strain, since most dogs don’t have immunity to that either.

However, there could potentially be a difference in terms of disease severity. Fatal H5N1 infections have occurred in many mammals and at least one dog, and we don’t want an H3N2/H5N1 recombinant virus that spreads nicely dog-to-dog and is more likely to cause severe disease.  The odds of that happening are extremely low, but not zero.

Also bear in mind that canine flu vaccines aim to reduce the severity of disease more than prevent infection altogether. That still might be useful, as a mildly affected dog with some degree of immunity might have a lower H3N2 viral burden, but it’s hard to say how much that would really help protect against recombination of flu viruses, even if we had more widespread vaccination in the dog population. Probably not too much.

Public health benefits would be less of a reason to promote vaccination of dogs against canine flu stains. Canine H3N2 flu poses little risk of infection of people, so a hybrid of canine H3N2 and H5N1 wouldn’t be expected to be more transmissible to people (even though it would potentially add some mammalian adaptations to an H5N1-related virus, which is definitely not the direction we want the virus to go). For dogs to be a flu “mixing vessel” of public health concern, a human flu strain would need to be involved. While dogs can occasionally be infected with human flu strains, the odds of a dog having H3N2, human seasonal flu and H5N1 at the same time are pretty low. Even then, whether or not the dog was vaccinated against H3N2 wouldn’t really affect the risk, since we’d be primarily concerned about the human flu and the H5N1 flu mixing in the dog, not whether or not H3N2 joins the party.

Should we change how we approach canine flu vaccination?

I’d mostly stick with our current approach, which is based on assessment of the risk of exposure of the dog to canine flu, and the risk of serious consequences should the dog get flu (e.g. elderly, brachycephalic, underlying heart or respiratory disease). Since there are some plausible dog health concerns about H3N2/H5N1 recombinants, I’d drop my threshold for vaccination in dogs that also have a higher risk of exposure to wild birds (or dairy farms in the US). Dogs that have a reasonable risk of exposure to both types of flu virus (canine and avian) would be higher on my list to vaccinate, but that’s a very small subset (currently), and the benefits of vaccination beyond H3N2 protection are probably very limited.